Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Sanochemia (09/12/2019)

15.12.2019

Sanochemia: The Management Board of Sanochemia Pharmazeutika AG will file an application for insolvency proceedings at the Vienna Commercial Court due to imminent insolvency. Due to the restriction of the GMP certificate as well as extensive economic burdens resulting from the past of the company, a liquidity gap has arisen in the company. This can not be covered by the cash flows from current operations, which has developed positively in recent months. The inclusion of external new investors has also proved impracticable in the current situation of the company. The Management Board has taken several steps to improve operations during the year, including significant cost-cutting programs and a capital increase by the core shareholder earlier this year. Despite these measures, as well as increased incoming orders in recent months, there has been no common, out-of-court solution due to the heterogeneous interests of the creditors. Since the restructuring talks conducted by the Management Board with the largest creditors of the Company could not be brought to a positive conclusion, there is no alternative to judicial insolvency proceedings in the view of Sanochemia.
Sanochemia: weekly performance: -1.86%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (09/12/2019)


Partners









latest 21st Austria

21st Austria weekly - Sanochemia (09/12/2019)


15.12.2019


Sanochemia: The Management Board of Sanochemia Pharmazeutika AG will file an application for insolvency proceedings at the Vienna Commercial Court due to imminent insolvency. Due to the restriction of the GMP certificate as well as extensive economic burdens resulting from the past of the company, a liquidity gap has arisen in the company. This can not be covered by the cash flows from current operations, which has developed positively in recent months. The inclusion of external new investors has also proved impracticable in the current situation of the company. The Management Board has taken several steps to improve operations during the year, including significant cost-cutting programs and a capital increase by the core shareholder earlier this year. Despite these measures, as well as increased incoming orders in recent months, there has been no common, out-of-court solution due to the heterogeneous interests of the creditors. Since the restructuring talks conducted by the Management Board with the largest creditors of the Company could not be brought to a positive conclusion, there is no alternative to judicial insolvency proceedings in the view of Sanochemia.
Sanochemia: weekly performance: -1.86%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (09/12/2019)




 

Bildnachweis

Aktien auf dem Radar:Semperit, DO&CO, Wienerberger, Warimpex, Rosenbauer, Zumtobel, Addiko Bank, FACC, Bawag, EVN, Kapsch TrafficCom, Lenzing, Österreichische Post, Signature AG.


Random Partner

Wiener Börse
Die Wiener Börse wurde im Jahr 1771 als eine der ersten Börsen weltweit gegründet. Zu den Hauptgeschäftsbereichen zählen der Handel am Kassamarkt und der Handel mit strukturierten Produkten. Zusätzliche Leistungen umfassen Datenverkauf, Indexentwicklung und -management sowie Seminare und Lehrgänge.

>> Besuchen Sie 56 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten